Health care CEOs say they can create successful growth strategies using partnerships outside the usual merger-and-acquisition route. NorthShore Medical Group CEO Dr. Joseph Golbus says some organizations aren't looking for a merger or lack a partner, and partnerships "are very much becoming a more prominent way of advancing your agenda."
US officials are worried that worsening relations with China could threaten exports of key drugs, including antibiotics, and drug ingredients to the US. Rosemary Gibson, author of "China Rx," said lack of access to drugs from China could disable US health care facilities "within months, if not days."
Health systems customizing EHRs should focus on health care provider operations and clinical decision support tools, says Kshitij Saxena, MD, chief medical informatics officer at Marshfield Clinic Health System in Wisconsin. Marshfield is revising its medical and surgical order set in inpatient and outpatient EHRs with an evidence-based vendor product.
Health care again took center stage in Thursday's night Democratic debate, with former Vice President Joe Biden attacking Sens. Bernie Sanders, I-Vt., and Elizabeth Warren, D-Mass., over the cost of their Medicare for All proposal. Eight of the presidential hopefuls in Thursday's debate support a public option or some sort other policy framework that would maintain a substantial role for private health insurance.
America's Health Insurance Plans and the Blue Cross Blue Shield Association sent comments to the House Committee on Small Business underscoring the importance of prior authorization, while physicians told lawmakers they wanted a say in how the process works. Dr. John Cullen, who testified on behalf of the Academy of Family Physicians, told the committee that generics should not be subject to prior authorization and physicians in alternative payment models also should be exempt from the process.
The White House's Office of Science Technology and Policy is seeking input from the public and biotech industry stakeholders on how biotechnology can drive economic growth, promote health and increase public benefit, and on whether the federal government should partner with the private sector, academia, professional organizations and others on basic science, translational research, product development and commercialization. The OSTP wants commenters to address policy or regulatory opportunities and gaps in translating basic science, developing and commercializing products, and areas where research funding could spur innovation.
The cost of US employer-sponsored medical benefits is predicted to climb by 6.5% next year, driven by higher care costs, flat or declining care utilization, and rising specialty drug prices, according to a report from Aon. Cancer, diabetes, musculoskeletal conditions, cardiovascular diseases and high blood pressure are the leading conditions driving US health care claims, the report found.
The Healthcare and Public Health Sector Coordinating Council recently issued guidance for sharing information on cyberthreats, risks and responses in the health care sector. The guidance is meant to help health care organizations understand the importance of cybersecurity information sharing, provide resources to start participating in threat sharing and help organizations establish an appropriate information management structure.